luminity
lantheus eu limited - perflutren - echocardiography - contrast media - this medicinal product is for diagnostic use only.luminity is an ultrasound contrast-enhancing agent for use in patients in whom non-contrast echocardiography was suboptimal (suboptimal is considered to indicate that at least two of six segments in the 4- or 2-chamber view of the ventricular border were not evaluable) and who have suspected or established coronary artery disease, to provide opacification of cardiac chambers and improvement of left ventricular endocardial border delineation at both rest and stress.
lantheus thallium[201tl] chloride 74mbq/ml injection multidose vial
global medical solutions australia pty limited - thallous(201tl) chloride, quantity: 74 mbq/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid; benzyl alcohol - thallous [201tl] chloride injection may be useful in myocardial perfusion imaging and for the diagnosis and localization of myocardial infarction. it may also be useful in conjunction with exercise stress testing as an adjunct to the diagnosis of ischemic heart disease. thallous [201tl] chloride injection may be useful for the localization of areas of parathyroid hyperactivity and for parathyroid imaging in patients with biochemically proven hyper-parathyroidism.
lantheus gallium (67ga) citrate injection
lantheus mi australia pty ltd - gallium(67ga) citrate -
lantheus gallium(67ga) citrate 74mbq/ml injection usp
global medical solutions australia pty limited - gallium (67ga) citrate, quantity: 74 mbq/ml - injection, solution - excipient ingredients: benzyl alcohol; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; sodium chloride; water for injections - indications as at 23 december 2003: gallium citrate ga67 injection, u.s.p. may be useful in demonstrating the presence of the following malignancies; hodgkins disease, lymphomas and bronchogenic carcinoma. positive ga67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.
lantheus thallium (201tl) chloride injection
lantheus mi australia pty ltd - thallous(201tl) chloride -
lantheus thallium (201tl) chloride injection
lantheus mi australia pty ltd - thallous(201tl) chloride -
luminity 225microlitres1.5ml solution for dispersion for injection vials
lantheus mi uk ltd - perflutren-containing lipid microspheres - solution for dispersion for injection - 150microlitre/1ml
neurolite- bicisate dihydrochloride kit
lantheus medical imaging, inc. - bicisate dihydrochloride (unii: b005p07v07) (bicisate - unii:3jxf0z0xoi) - bicisate dihydrochloride 0.9 mg - neurolite single photon emission computerized tomography (spect) is indicated as an adjunct to conventional ct or mri imaging in the localization of stroke in patients in whom stroke has already been diagnosed. neurolite is not indicated for assessment of functional viability of brain tissue. also, neurolite is not indicated for distinguishing between stroke and other brain lesions. none known.
technelite molybdenum(99mo)/technetium(99mtc) sterile generator for production of sodium pertechnetate(99mtc) injection multidose vial
global medical solutions australia pty limited - sodium pertechnetate(99mtc), quantity: 18.5 gbq - injection, solution - excipient ingredients: water for injections; sodium chloride - technetium [99mtc] generator is used for the preparation of sodium pertechnetate 99m tc injection. sodium pertechnetate 99mtc is used as an agent for: brain imaging, thyroid imaging, salivary gland imaging, blood pool imaging.
xenon- xenon xe-133 gas
lantheus medical imaging, inc. - xenon xe-133 (unii: x3p9a5hnyf) (xenon xe-133 - unii:x3p9a5hnyf) - xenon xe-133 10 mci - inhalation of xenon xe 133 gas has proved valuable for the evaluation of pulmonary function and for imaging the lungs. it may also be applied to assessment of cerebral flow. none known.